section name header

Indications ⬇

REMS


Contraind./Precautions ⬆ ⬇

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects ⬆ ⬇

Derm: allergic contact dermatitis, atrophy, burning, dryness, edema, folliculitis, hypersensitivity reactions, hypertrichosis, hypopigmentation, irritation, maceration, miliaria, perioral dermatitis, secondary infection, striae

EENT: cataracts, glaucoma

Endo: adrenal suppression (use of occlusive dressings, long-term therapy)

Interactions ⬆ ⬇

Drug-drug:

Availability ⬆ ⬇

(Generic available)

Route/Dosage ⬆ ⬇

US Brand Names ⬆ ⬇

Diprolene, Diprolene AF, Luxiq, Sernivo

Action ⬆ ⬇

  • Suppresses normal immune response and inflammation.
Therapeutic effects:
  • Suppression of dermatologic inflammation and immune processes.
  • Reduction in plaques.

Classifications ⬆ ⬇

Therapeutic Classification: corticosteroids

Pharmacologic Classification: corticosteroids

Pharmacokinetics ⬆ ⬇

Absorption: Minimal. Prolonged use on large surface areas or large amounts applied or use of occlusive dressings may increase systemic absorption.

Distribution: Remains primarily at site of action.

Metabolism/Excretion: Usually metabolized in skin; modified to resist local metabolism and have a prolonged local effect.

Half-Life: 3–5 hr (plasma), 36–54 hr (tissue); adrenal suppression lasts 3.25 days.

Canadian Brand Names ⬆ ⬇

Betaderm, Beteflam, Celestoderm V, Celestoderm V/2, Diprosone

Time/Action Profile ⬆ ⬇

(response depends on condition being treated)

ROUTEONSETPEAKDURATION
Topicalmin-hrshrs-dayshrs-days

Patient/Family Teaching ⬆ ⬇

Pronunciation ⬆ ⬇

bay-ta-METH-a-sone

Code ⬆

NDC Code